BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26523099)

  • 1. Promises and paradoxes of regulatory T cells in inflammatory bowel disease.
    Lord JD
    World J Gastroenterol; 2015 Oct; 21(40):11236-45. PubMed ID: 26523099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.
    Yamada A; Arakaki R; Saito M; Tsunematsu T; Kudo Y; Ishimaru N
    World J Gastroenterol; 2016 Feb; 22(7):2195-205. PubMed ID: 26900284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disrupted regulatory T cell homeostasis in inflammatory bowel diseases.
    Pedros C; Duguet F; Saoudi A; Chabod M
    World J Gastroenterol; 2016 Jan; 22(3):974-95. PubMed ID: 26811641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases.
    Hovhannisyan Z; Treatman J; Littman DR; Mayer L
    Gastroenterology; 2011 Mar; 140(3):957-65. PubMed ID: 21147109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal Immunity Related to FOXP3
    Cho J; Kim S; Yang DH; Lee J; Park KW; Go J; Hyun CL; Jee Y; Kang KS
    J Korean Med Sci; 2018 Dec; 33(52):e336. PubMed ID: 30584414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The balance of intestinal Foxp3+ regulatory T cells and Th17 cells and its biological significance.
    Shen X; Du J; Guan W; Zhao Y
    Expert Rev Clin Immunol; 2014 Mar; 10(3):353-62. PubMed ID: 24483245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis.
    Cuadrado E; Alonso M; de Juan MD; Echaniz P; Arenas JI
    World J Gastroenterol; 2008 Mar; 14(10):1521-7. PubMed ID: 18330941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoleamine 2,3-dioxygenase and regulatory t cells in intestinal mucosa in children with inflammatory bowel disease.
    Sznurkowska K; Żawrocki A; Sznurkowski J; Iżycka-Świeszewska E; Landowski P; Szlagatys-Sidorkiewicz A; Plata-Nazar K; Kamińska B
    J Biol Regul Homeost Agents; 2017; 31(1):125-131. PubMed ID: 28337881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of antibiotics for treatment of inflammatory bowel disease.
    Nitzan O; Elias M; Peretz A; Saliba W
    World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating and Tissue-Resident CD4
    Hegazy AN; West NR; Stubbington MJT; Wendt E; Suijker KIM; Datsi A; This S; Danne C; Campion S; Duncan SH; Owens BMJ; Uhlig HH; McMichael A; ; Bergthaler A; Teichmann SA; Keshav S; Powrie F
    Gastroenterology; 2017 Nov; 153(5):1320-1337.e16. PubMed ID: 28782508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Tom MR; Li J; Ueno A; Fort Gasia M; Chan R; Hung DY; Chenoo S; Iacucci M; Jijon HB; Kaplan GG; Beck PL; Panaccione R; Barkema HW; Buret AG; Yajnik V; Ghosh S
    Inflamm Bowel Dis; 2016 Jul; 22(7):1596-608. PubMed ID: 27306067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation.
    Kulkarni N; Meitei HT; Sonar SA; Sharma PK; Mujeeb VR; Srivastava S; Boppana R; Lal G
    J Autoimmun; 2018 Mar; 88():121-130. PubMed ID: 29126851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of the Histone Methyltransferase Enhancer of Zeste Homolog 2 (EZH2) in the Pathobiological Mechanisms Underlying Inflammatory Bowel Disease (IBD).
    Sarmento OF; Svingen PA; Xiong Y; Sun Z; Bamidele AO; Mathison AJ; Smyrk TC; Nair AA; Gonzalez MM; Sagstetter MR; Baheti S; McGovern DP; Friton JJ; Papadakis KA; Gautam G; Xavier RJ; Urrutia RA; Faubion WA
    J Biol Chem; 2017 Jan; 292(2):706-722. PubMed ID: 27909059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients.
    Reikvam DH; Perminow G; Lyckander LG; Gran JM; Brandtzaeg P; Vatn M; Carlsen HS
    Scand J Gastroenterol; 2011 May; 46(5):550-60. PubMed ID: 21281255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
    Lord JD; Shows DM; Chen J; Thirlby RC
    PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.